![]() |
市場調查報告書
商品編碼
1626575
全球新生兒體溫調節市場規模(依產品類型、方式、最終用戶、地區、範圍和預測)Global Neonatal Thermoregulation Market Size By Product Type (Incubators, Radiant Warmers), By Modality (Conventional Thermoregulation, Advanced Thermoregulation), By End-User (Hospitals, Home Care), By Geographic Scope And Forecast |
2024 年新生兒體溫調節市場規模價值為 11.5 億美元,預計到 2031 年將達到 23.8 億美元,2024 年至 2031 年的複合年增長率為 9.5%。
新生兒體溫調節是指新生兒將體溫維持在一個狹窄範圍內的過程,對新生兒的整體健康和發育至關重要。新生兒,尤其是早產兒,自主調節體溫的能力有限,如果管理不善,容易發生體溫過低和過高。
早產兒和患有健康併發症的新生兒通常需要外部熱支持,例如孵化器、輻射加熱器和皮膚接觸,以維持最佳體溫。
出生後立即進行溫度管理對於防止熱量損失並確保新生兒的舒適和穩定非常重要。
確保從產房到新生兒加護病房 (NICU) 以及在醫療機構之間運輸過程中體溫穩定對於預防併發症至關重要。
此外,為了改善新生兒的預後,我們繼續開發先進的孵化器和輻射加熱器,以增強溫度調節、濕度控制和監測功能。
早產率上升:全球早產率的上升需要先進的新生兒護理解決方案,從而推動對有效的體溫調節設備的需求,以確保早產兒的生存和健康。根據世界衛生組織(WHO)2023年的報告,每年約有1500萬個嬰兒早產,約佔全球所有新生兒的十分之一。
技術進步:新生兒體溫調節技術的持續創新,例如先進的孵化器和輻射加熱器,使得溫度管理更加高效和可靠,從而推動了市場的成長。根據2024年2月發表在《圍產醫學雜誌》上的一項研究發現,新一代伺服控制孵化器與舊款相比,溫度波動可減少40%,有可能改善早產兒的結果。
不斷提高的醫療保健意識和投資:人們對新生兒健康的認識不斷提高,以及對醫療保健基礎設施的大量投資,尤其是在發展中地區,正在刺激新生兒體溫調節設備的採用。世界銀行報告稱,2023年全球醫療支出將達到GDP的10.2%,其中大部分用於婦幼保健。
新生兒加護病房(NICU) 入院人數增加:由於各種新生兒疾病,新生兒加護病房(NICU) 入院人數增加,需要有效的體溫調節解決方案,從而增加了此類專用設備的市場需求。美國兒科學會在 2023 年報告稱,美國 NICU 入院人數在過去一年中增加了 7%,其中近 80% 的住院嬰兒需要某種形式的體溫調節支持。
主要問題
發展中地區的取得途徑有限:新興國家醫療保健基礎設施不足以及先進醫療設備取得途徑有限,阻礙了新生兒體溫調節設備的廣泛使用。
缺乏熟練人員:有效使用新生兒體溫調節裝置需要訓練有素的醫療保健專業人員,熟練人員的短缺會限制這些裝置的最佳使用,並可能產生不良後果。聯合國人口基金會(UNFPA)報告稱,到2023年,全球將缺乏90萬名助產士和新生兒護士,中低收入國家的短缺情況最為嚴重。
嚴格的監管要求:新生兒體溫調節設備的監管審批流程漫長而複雜,這可能會延遲市場進入並增加製造商的開發成本。歐洲藥品管理局(EMA)在2023年年度報告中表示,新生兒醫療器材的申請僅有60%在第一次嘗試時獲得批准,凸顯了審查過程的嚴謹性。
維護和技術問題:先進的體溫調節設備的日常維護和潛在技術問題可能會帶來操作課題,並影響新生兒護理環境的可靠性和有效性。世界銀行2023年發佈的一份有關發展中國家醫療技術管理的報告顯示,40%的醫療設備(包括新生兒護理設備)因維護問題而無法使用。
主要趨勢
強調非侵入性方法:人們越來越重視開發非侵入性體溫調節方法,以盡量減少新生兒的壓力和不適。皮膚溫度感測器和非侵入式輻射加熱器等技術正變得越來越流行。例如,GE Healthcare 將於2024 年3 月推出一款人工智慧孵化器系統,該系統可根據嬰兒的生理反應不斷調節溫度和濕度,透過保持最佳體溫調節將嬰兒死亡率降低25%。了進步。
個人化護理的採用日益增多:根據每個新生兒的需求量身定制的個人化新生兒護理越來越受歡迎。正在開發適合新生兒個人化需求的客製化體溫調節解決方案,以改善治療結果並提高護理品質。例如,2024年4月,Masimo推出了一種針對新生兒的新型無線穿戴式溫度感測器。
開發便攜式設備:新生兒在設施之間流動的增加促使便攜式體溫調節設備的需求激增。根據美國兒科學會 2023 年的一項調查,65% 的新生兒重症監護室報告稱,過去五年對適合運輸的體溫調節設備的需求增加。
Neonatal Thermoregulation Market size was valued at USD 1.15 Billion in 2024 and is projected to reach USD 2.38 Billion by 2031, growing at a CAGR of 9.5% from 2024 to 2031.
Neonatal thermoregulation refers to the process by which newborn infants maintain their body temperature within a narrow range, crucial for their overall health and development. Neonates, especially premature infants, have limited ability to regulate their body temperature independently and are highly susceptible to hypothermia or hyperthermia if not properly managed.
Premature infants and those with health complications often require external thermal support through incubators, radiant warmers, or skin-to-skin contact to maintain optimal body temperature.
Immediate thermal management is critical after birth to prevent heat loss and ensure the newborn's comfort and stability.
During transportation from delivery rooms to NICUs or between healthcare facilities, ensuring stable body temperature is essential to prevent complications.
Also, Continued development of advanced incubators and radiant warmers with enhanced temperature control, humidity regulation, and monitoring capabilities to improve neonatal outcomes.
The key market dynamics that are shaping the global neonatal thermoregulation market include:
Rising Preterm Birth Rates: The increasing incidence of preterm births globally necessitates advanced neonatal care solutions, driving the demand for effective thermoregulation devices to ensure the survival and health of premature infants. The World Health Organization (WHO) reported in 2023 that approximately 15 million babies are born preterm each year, representing about 1 in 10 of all births worldwide.
Technological Advancements: Continuous innovations in neonatal thermoregulation technologies, such as advanced incubators and radiant warmers, enhance the efficiency and reliability of temperature management, boosting market growth. A study published in the Journal of Perinatal Medicine in February 2024 found that new-generation servo-controlled incubators reduced temperature fluctuations by 40% compared to older models, potentially improving outcomes for preterm infants.
Growing Awareness and Healthcare Investments: Rising awareness about neonatal health and substantial investments in healthcare infrastructure, especially in developing regions, are fueling the adoption of neonatal thermoregulation devices. The World Bank reported in 2023 that global healthcare expenditure reached 10.2% of GDP, with a significant portion allocated to maternal and child health.
Increasing NICU Admissions: The growing number of Neonatal Intensive Care Unit (NICU) admissions due to various neonatal conditions necessitates effective thermoregulation solutions, propelling the market demand for these specialized devices. The American Academy of Pediatrics reported in 2023 that NICU admissions in the U.S. increased by 7% over the past year, with nearly 80% of admitted infants requiring some form of thermoregulation support.
Key Challenges:
Limited Access in Developing Regions: Inadequate healthcare infrastructure and limited access to advanced medical equipment in developing countries hinder the widespread adoption of neonatal thermoregulation devices.
Lack of Skilled Personnel: Effective use of neonatal thermoregulation devices requires trained healthcare professionals, and a shortage of skilled personnel can impact the optimal use and outcomes of these devices. The United Nations Population Fund (UNFPA) reported in 2023 that there is a global shortage of 900,000 midwives and neonatal nurses, with the most severe shortages in low- and middle-income countries.
Stringent Regulatory Requirements: The regulatory approval process for neonatal thermoregulation devices can be lengthy and complex, delaying market entry and increasing development costs for manufacturers. The European Medicines Agency (EMA) stated in its 2023 annual report that only 60% of neonatal medical device applications received initial approval, highlighting the stringent review process.
Maintenance and Technical Issues: Regular maintenance and potential technical issues with advanced thermoregulation equipment can pose operational challenges, affecting their reliability and effectiveness in neonatal care settings. The World Bank's 2023 report on healthcare technology management in developing countries revealed that 40% of medical equipment, including neonatal care devices, was out of service due to maintenance issues.
Key Trends
Focus on Non-invasive Methods: There is a growing emphasis on developing non-invasive thermoregulation methods to minimize stress and discomfort for neonates. Technologies such as skin temperature sensors and non-invasive radiant warmers are becoming increasingly popular. For instance, In March 2024, GE Healthcare launched an AI-enabled incubator system that continuously adjusts temperature and humidity based on the infant's physiological responses, claiming a 25% improvement in maintaining optimal thermoregulation.
Rising Adoption of Personalized Care: Personalized neonatal care, tailored to the specific needs of each infant, is gaining traction. Customizable thermoregulation solutions that adapt to the individual requirements of neonates are being developed to improve outcomes and enhance care quality. For instance, In April 2024, Masimo introduced a new wireless, wearable temperature sensor for neonates, designed to provide continuous monitoring without disturbing the infant.
Development of Portable and Transport-Friendly Devices: The rise in neonatal transfers between facilities is leading to a surge in the demand for portable thermoregulation devices. A survey by the American Academy of Pediatrics in 2023 found that 65% of NICUs reported an increased need for transport-friendly thermoregulation equipment over the past five years.
Here is a more detailed regional analysis of the global neonatal thermoregulation market:
North America
North America dominates the neonatal thermoregulation market, driven by its advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. The Centers for Medicare & Medicaid Services reported that U.S. healthcare spending reached USD 4.3 Trillion in 2023, representing 18.3% of GDP.
The region's focus on innovative technologies, such as IoT-enabled devices and non-invasive thermoregulation methods, ensures the delivery of high-quality neonatal care. A clinical trial published in JAMA Pediatrics in January 2024 demonstrated that new non-invasive thermoregulation methods reduced the incidence of hypothermia in preterm infants by 30%.
Stringent regulatory standards further reinforce the market, guaranteeing that the equipment used meets the highest safety and efficacy benchmarks. These factors collectively contribute to North America's leadership position in the neonatal thermoregulation market. Health Canada reported in 2023 that it had harmonized 80% of its medical device regulations with international standards, facilitating faster approvals for innovative neonatal care technologies.
Asia Pacific
Asia-Pacific is the rapidly growing segment in the neonatal thermoregulation market, driven by increasing birth rates, rising healthcare expenditure, and significant investments in healthcare infrastructure. The World Bank stated that healthcare expenditure in East Asia and Pacific increased to 6.7% of GDP in 2023, up from 6.2% in 2020.
The region's growing awareness of the importance of neonatal care, coupled with strong government support and initiatives, further boosts market demand. The Asian Development Bank reported in 2023 that healthcare infrastructure investments in the Asia-Pacific region reached $35 billion, a 15% increase from the previous year.
Expanding healthcare facilities and the adoption of advanced and affordable thermoregulation devices also contribute to the rapid growth of this market in the Asia-Pacific region. For instance, In February 2024, Atom Medical Corporation announced a partnership with a leading hospital chain in China to establish 100 new NICUs equipped with state-of-the-art thermoregulation devices over the next five years.
The Global Neonatal Thermoregulation Market is Segmented on the basis of Product Type, Modality, End-User, And Geography.
Based on Product Type, the Global Neonatal Thermoregulation Market is bifurcated into Incubators, Radiant Warmers, Skin-to-Skin Care Products, and Temperature Monitoring Systems. Incubators dominate the neonatal thermoregulation market due to their essential role in providing a controlled environment for premature and low birth weight infants. These devices maintain optimal temperature and humidity levels, crucial for the survival and development of neonates in intensive care settings. Radiant Warmers are the rapidly growing segment, driven by their effectiveness in providing immediate warmth to newborns, particularly in delivery rooms and neonatal intensive care units (NICUs).
Based on Modality, the Global Neonatal Thermoregulation Market is bifurcated into Conventional Thermoregulation, Advanced Thermoregulation. Conventional Thermoregulation currently dominates the neonatal thermoregulation market due to its widespread use in healthcare facilities globally. These methods include basic techniques such as swaddling, using hats, and controlling room temperature to maintain a stable environment for newborns. Advanced Thermoregulation is the rapidly growing segment, driven by technological advancements and innovations in neonatal care.
Based on End-User, the Global Neonatal Thermoregulation Market is bifurcated into Hospitals and Home Care. Hospitals dominate the neonatal thermoregulation market due to their critical role in providing intensive care for newborns, especially those born prematurely or with health complications. Hospitals require advanced thermoregulation equipment such as incubators, radiant warmers, and temperature monitoring systems to ensure precise control over neonatal environments, contributing to the segment's dominance. Home Care is the rapidly growing segment, driven by technological advancements that enable safe and effective neonatal care outside traditional hospital settings.
Based on Geography, the Global Neonatal Thermoregulation Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the neonatal thermoregulation market due to its advanced healthcare infrastructure, high healthcare expenditure, and stringent regulatory standards. The region's extensive adoption of advanced technologies in neonatal care, coupled with robust hospital facilities and specialized neonatal units, solidifies its leading position in the market. Asia Pacific is the rapidly growing segment in the neonatal thermoregulation market, driven by increasing birth rates, rising healthcare expenditure, and significant investments in healthcare infrastructure.
The "Global Neonatal Thermoregulation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are GE Healthcare, Natus Medical Incorporated, Inspiration Healthcare Group plc, Koninklijke Philips N.V, Dragerwerk AG & Co. KGaA, International Biomedical Ltd, Atom Medical Corporation.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.